News & Updates
Showing Endocrinology articles
Showing
PD Test - Exact 50 char Semaglutide benefits exten
The weight loss and heart failure (HF) benefits of semaglutide extend to patients with obesity-related HF with preserved ejection fraction (HFpEF) and type 2 diabetes (T2D) in the STEP-HFpEF DM trial, fuelling speculation that semaglutide may have cardiovascular effects beyond weight loss.
PD Test - Exact 50 char Semaglutide benefits exten
04 May 2024
Smartphone app helps control blood sugar in people at risk of T2D
Use of a smartphone application (app) and an intermittently scanned continuous glucose monitoring (isCGM) results in better glycaemic control, lower carbohydrate intake, and weight loss in people at increased risk of type 2 diabetes (T2D), reports a study.
Smartphone app helps control blood sugar in people at risk of T2D
29 Apr 2024
Stand Against Prediabetes campaign aiming for early detection, better management
The ‘Stand Against Prediabetes; Don’t Sugarcoat It’ (SAPd) program was recently launched in Putrajaya.
Stand Against Prediabetes campaign aiming for early detection, better management
26 Apr 2024
Hyperglycaemia, dyslipidemia up risk of diabetic kidney disease
A recent study has identified six common metabolic profiles among patients with type 2 diabetes (T2D). In addition, severe hyperglycaemia and moderate dyslipidemia are associated with an increased risk of diabetic kidney disease (DKD).